This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Vallon Pharmaceuticals Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	no data
Eigentum des Geschäftsführers	n/a
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	keine Daten

Jüngste Management Updates

Recent updates

Vallon Pharmaceuticals reports Q2 results

Jul 28

We're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate

Dec 15

We Think Vallon Pharmaceuticals (NASDAQ:VLON) Needs To Drive Business Growth Carefully

Aug 17

Will Vallon Pharmaceuticals (NASDAQ:VLON) Spend Its Cash Wisely?

May 17

Geschäftsführer

Vallon Pharmaceuticals hat keinen Geschäftsführer, oder es liegen keine verfügbaren Daten vor.

This company is no longer active

Vallon Pharmaceuticals Management

Management Kriterienprüfungen 0/4

Wichtige Informationen

Jüngste Management Updates

High number of new and inexperienced directors

Vallon Pharmaceuticals, Inc. Announces Board Changes

Less than half of directors are independent

Vallon Pharmaceuticals, Inc. Announces Elimination of Penny S. Toren as Senior Vice President

Key Executive notifies of intention to sell stock

Vallon Pharmaceuticals, Inc. Announces Resignation of Ofir Levi as Member of the Board of Directors and as Chairman of the Board

Recent updates

High number of new and inexperienced directors

Vallon Pharmaceuticals reports Q2 results

Vallon Pharmaceuticals Receives Non-Compliance Letter from Nasdaq

Vallon Pharmaceuticals, Inc. Announces Board Changes

Vallon Pharmaceuticals, Inc. Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIR

Less than half of directors are independent

Vallon Pharmaceuticals, Inc. Announces Elimination of Penny S. Toren as Senior Vice President

Key Executive notifies of intention to sell stock

Vallon Pharmaceuticals, Inc. Announces Resignation of Ofir Levi as Member of the Board of Directors and as Chairman of the Board

Key Executive notifies of intention to sell stock

Vallon Pharmaceuticals, Inc. Announces Appointment of Meenu Karson to Board of Directors

Vallon Pharmaceuticals, Inc. Provides an Update on its Development Programs, ADAIR and ADMIR

Vallon Pharmaceuticals Presents New Data from Adult Stimulant Abuse Pattern Survey at the APSARD 2022 Annual Conference

Vallon Pharmaceuticals, Inc. Announces Achievement of Last Patient Last Visit in Pivotal SEAL Study for Lead Program, ADAIR

We're Keeping An Eye On Vallon Pharmaceuticals' (NASDAQ:VLON) Cash Burn Rate

High number of new and inexperienced directors

High number of new and inexperienced directors

We Think Vallon Pharmaceuticals (NASDAQ:VLON) Needs To Drive Business Growth Carefully

Independent Non-Executive Director recently bought US$72k worth of stock

Will Vallon Pharmaceuticals (NASDAQ:VLON) Spend Its Cash Wisely?

Vallon Pharmaceuticals Provides Update on its Development Programs, ADAIR and ADMIR

Vallon Pharmaceuticals, Inc. Appoints Marella Thorell to the Board of Directors

Vallon Pharmaceuticals, Inc. has completed an IPO in the amount of $18 million.

Geschäftsführer